Crossed the 20 sma yesterday. We are also way oversold on a daily basis.
My guess is a slow rise for a few days, absent any news.
On a side note clsn news hurts all small bio tech stocks. It reminds people of the higher than normal risk
CLSN is garbage & the impact on other companies is not relevant. KERX got an approval & the stock shot up but it did not impact the performance of other small developmental biotechs. Maybe if you had CLSN then it would be a different story.